100 related articles for article (PubMed ID: 17328944)
1. Cigarette smoking impairs bradykinin-stimulated tissue plasminogen activator release in human coronary circulation.
Takashima H; Matsumoto T; Nakae I; Yamane T; Horie M
Thromb Res; 2007; 120(6):791-6. PubMed ID: 17328944
[TBL] [Abstract][Full Text] [Related]
2. Bradykinin stimulates the release of tissue plasminogen activator in human coronary circulation: effects of angiotensin-converting enzyme inhibitors.
Minai K; Matsumoto T; Horie H; Ohira N; Takashima H; Yokohama H; Kinoshita M
J Am Coll Cardiol; 2001 May; 37(6):1565-70. PubMed ID: 11345366
[TBL] [Abstract][Full Text] [Related]
3. Marked impairment of protease-activated receptor type 1-mediated vasodilation and fibrinolysis in cigarette smokers: smoking, thrombin, and vascular responses in vivo.
Lang NN; Gudmundsdóttir IJ; Boon NA; Ludlam CA; Fox KA; Newby DE
J Am Coll Cardiol; 2008 Jul; 52(1):33-9. PubMed ID: 18582632
[TBL] [Abstract][Full Text] [Related]
4. Association between brachial-ankle pulse wave velocity and endothelium-dependent and -independent coronary vasomotor function.
Yoshino T; Nakae I; Matsumoto T; Mitsunami K; Horie M
Clin Exp Pharmacol Physiol; 2011 Jan; 38(1):34-41. PubMed ID: 21039754
[TBL] [Abstract][Full Text] [Related]
5. Impaired myocardial t-PA release in patients with coronary artery disease.
Osterlund B; Jern S; Jern C; Seeman-Lodding H; Ostman M; Johansson G; Biber B
Acta Anaesthesiol Scand; 2008 Nov; 52(10):1375-84. PubMed ID: 19025531
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme inhibition increases basal vascular tissue plasminogen activator release in women but not in men.
Pretorius M; Luther JM; Murphey LJ; Vaughan DE; Brown NJ
Arterioscler Thromb Vasc Biol; 2005 Nov; 25(11):2435-40. PubMed ID: 16166566
[TBL] [Abstract][Full Text] [Related]
7. Brachial artery flow-mediated vasodilation is correlated with coronary vasomotor and fibrinolytic responses induced by bradykinin.
Tarutani Y; Matsumoto T; Takashima H; Yamane T; Horie M
Hypertens Res; 2005 Jan; 28(1):59-66. PubMed ID: 15969256
[TBL] [Abstract][Full Text] [Related]
8. Impaired coronary tissue plasminogen activator release is associated with coronary atherosclerosis and cigarette smoking: direct link between endothelial dysfunction and atherothrombosis.
Newby DE; McLeod AL; Uren NG; Flint L; Ludlam CA; Webb DJ; Fox KA; Boon NA
Circulation; 2001 Apr; 103(15):1936-41. PubMed ID: 11306520
[TBL] [Abstract][Full Text] [Related]
9. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme insertion/deletion polymorphism modulates coronary release of tissue plasminogen activator in response to bradykinin.
Ohira N; Matsumoto T; Tamaki S; Takashima H; Tarutani Y; Yamane T; Yasuda Y; Horie M
Hypertens Res; 2004 Jan; 27(1):39-45. PubMed ID: 15055254
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme inhibition but not angiotensin II type 1 receptor antagonism augments coronary release of tissue plasminogen activator in hypertensive patients.
Matsumoto T; Minai K; Horie H; Ohira N; Takashima H; Tarutani Y; Yasuda Y; Ozawa T; Matsuo S; Kinoshita M; Horie M
J Am Coll Cardiol; 2003 Apr; 41(8):1373-9. PubMed ID: 12706934
[TBL] [Abstract][Full Text] [Related]
12. Impaired capacity for acute endogenous fibrinolysis in smokers is restored by ascorbic acid.
Kaehler J; Koeke K; Karstens M; Schneppenheim R; Meinertz T; Heitzer T
Free Radic Biol Med; 2008 Feb; 44(3):315-21. PubMed ID: 18215739
[TBL] [Abstract][Full Text] [Related]
13. Smoking impairs bradykinin-stimulated t-PA release.
Pretorius M; Rosenbaum DA; Lefebvre J; Vaughan DE; Brown NJ
Hypertension; 2002 Mar; 39(3):767-71. PubMed ID: 11897760
[TBL] [Abstract][Full Text] [Related]
14. [Impaired coronary flow reserve due to long-term smoking recovers after quitting].
Tanaka T; Oka Y; Tawara I; Sada T; Kira Y
J Cardiol; 1998 Jun; 31(6):337-41. PubMed ID: 9666387
[TBL] [Abstract][Full Text] [Related]
15. Effect of sulfaphenazole on tissue plasminogen activator release in normotensive subjects and hypertensive patients.
Giannarelli C; Virdis A; De Negri F; Magagna A; Duranti E; Salvetti A; Taddei S
Circulation; 2009 Mar; 119(12):1625-33. PubMed ID: 19289643
[TBL] [Abstract][Full Text] [Related]
16. Impact of paraoxonase polymorphism (Q192R) on endothelial function in intact coronary circulation.
Yamane T; Matsumoto T; Nakae I; Takashima H; Tarutani Y; Tamaki S; Horie M
Hypertens Res; 2006 Jun; 29(6):417-22. PubMed ID: 16940704
[TBL] [Abstract][Full Text] [Related]
17. [Changes in tissue plasminogen activator and plasminogen activator inhibitor during administration of nitroglycerine into internal thoracic artery in dogs with acute myocardial ischemia].
Wu X; Wang CF; Sheng J; Zhu J
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Sep; 16(9):527-9. PubMed ID: 15355613
[TBL] [Abstract][Full Text] [Related]
18. Effect of ACE inhibition on the fibrinolytic system in patients requiring coronary artery bypass grafting.
Walter T; Szabo S; Kazmaier S; Suselbeck T; Borggrefe M; Hoffmeister HM
Thorac Cardiovasc Surg; 2009 Sep; 57(6):368-71. PubMed ID: 19707983
[TBL] [Abstract][Full Text] [Related]
19. Influence of oral contraceptive use on endothelial t-PA release in healthy premenopausal women.
Hoetzer GL; Stauffer BL; Greiner JJ; Casas Y; Smith DT; DeSouza CA
Am J Physiol Endocrinol Metab; 2003 Jan; 284(1):E90-5. PubMed ID: 12388132
[TBL] [Abstract][Full Text] [Related]
20. Bradykinin stimulates tissue plasminogen activator release in human vasculature.
Brown NJ; Gainer JV; Stein CM; Vaughan DE
Hypertension; 1999 Jun; 33(6):1431-5. PubMed ID: 10373228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
